(22) Kelly Brown on Twitter: "Pfizer added new and peculiar items deep in its business risk disclosures re: clinical trial data, today in its Q4 earnings. (1/3) "...risks associated with...further information regarding the quality of pre-clinical, clinica
Kelly Brown : Pfizer added new and peculiar items deep in its business risk disclosures re: clinical trial data, today in its Q4… https://t.co/yDNi38oICW